What are the recommended next steps after a low fetal fraction result on a non‑invasive prenatal test (NIPT)?

Low Fetal Fraction NIPT: Recommended Next Steps

When NIPT returns a low fetal fraction result, the most appropriate next step is to repeat the test with a second blood draw, which successfully yields results in approximately 63-71% of cases, particularly when performed at least 7-14 days after the initial sample 1, 2.

Immediate Management Algorithm

Step 1: Repeat NIPT Testing

• Redraw timing: Optimal results occur when repeat sampling is performed 7-14 days after initial draw 2
• Success rates:
  • Overall informative redraw rate: 70.6% 2
  • For insufficient fetal fraction specifically: 62.9% 2
  • Success increases rapidly over first 8 days, then plateaus 2

Step 2: Factors Affecting Repeat Test Success

The likelihood of obtaining results on redraw depends heavily on:

• Initial fetal fraction level: Lower initial FF correlates with lower redraw success 2
• Maternal weight: Higher BMI significantly reduces success rates 2, 3
• Time interval: Longer intervals (up to 14 days) improve outcomes 2
• Gestational age: Surprisingly, NOT a major determinant of redraw success 2

Step 3: If Repeat NIPT Fails or Patient Declines

Offer diagnostic testing with genetic counseling 1. The ACMG and professional societies recommend:

• Chorionic villus sampling (CVS): 10-13 weeks gestation 4
• Amniocentesis: ≥15 weeks gestation 4
• Genetic counseling: Essential for informed decision-making 5

Critical Clinical Context

Aneuploidy Risk Assessment

The evidence regarding aneuploidy risk with low fetal fraction is mixed but reassuring:

• Some studies show marginally increased aneuploidy association 6, 7
• However, the proportion of trisomy events is NOT significantly increased in low FF cases (OR 1.37, p=0.714) 6
• Most no-call results that are successfully repeated return negative results 6
• Professional societies recommend offering diagnostic testing, but this reflects caution rather than high risk 1

Adverse Pregnancy Outcomes: The More Important Concern

Low fetal fraction is independently associated with increased risk of adverse pregnancy outcomes, which is arguably more clinically significant than the aneuploidy risk 3, 8, 9:

• Hypertensive disorders of pregnancy (HDP): OR 1.66 (95% CI 1.34-2.06) 8; 5.17% vs 1.91% in controls 9
• Gestational diabetes (GDM): OR 1.27 (95% CI 1.03-1.56) 8
• Small for gestational age/fetal growth restriction (SGA/FGR): OR 1.63 (95% CI 1.32-2.03) 8
• Composite adverse outcome: Adjusted OR 1.946 for placental compromise 9
• Overall composite adverse outcomes: 59.1% vs 29% in normal FF group 3

Enhanced Surveillance Protocol

Given the association with adverse outcomes, implement enhanced monitoring:

1. Increased antenatal surveillance for signs of placental insufficiency
2. Serial growth ultrasounds in third trimester
3. Blood pressure monitoring for early detection of HDP
4. GDM screening (though this is routine)
5. Consider earlier or more frequent fetal surveillance in third trimester

Common Pitfalls to Avoid

Pitfall 1: Assuming Low FF Equals High Aneuploidy Risk

• Low FF is more strongly associated with placental dysfunction than aneuploidy 3, 8, 9
• Don't over-emphasize chromosomal risk when counseling patients

Pitfall 2: Not Accounting for Maternal Factors

• High BMI is the strongest predictor of persistent low FF 6, 2, 3
• African American race associated with higher low FF rates 3
• These factors should guide counseling about redraw success likelihood

Pitfall 3: Rushing to Invasive Testing

• A repeat blood draw is successful in the majority of cases 6, 2
• Invasive testing carries procedure-related loss risk (1:300-600 for amniocentesis) 10
• Allow adequate time interval (7-14 days) before redraw 2

Pitfall 4: Ignoring the Obstetric Implications

• The most important clinical implication of low FF may not be aneuploidy screening failure, but rather the association with adverse pregnancy outcomes 3, 8, 9
• Ensure appropriate obstetric follow-up is arranged regardless of whether aneuploidy screening is completed

Alternative Screening Options

If repeat NIPT fails and patient declines invasive testing:

• Quad screen (second trimester serum screening) if still within appropriate gestational age window 11
• Detailed anatomic ultrasound to assess for structural anomalies associated with aneuploidy 11
• Accept limitations of incomplete aneuploidy screening while focusing on obstetric surveillance

Technology Considerations

Different NIPT platforms have varying failure rates 7:

• Massive parallel sequencing: 1.58% failure rate (lowest)
• SNP-based methods: 6.39% failure rate (highest)
• This may influence choice of testing platform for repeat testing 7